[1] Wu X, Wang Y, Cui Y, et al. Hepatitis B virus directly promotes collagen I expression of LX-2 cells without infection in vitro[J]. Hepatol Res, 2012,42(9):911-921. [2] Li H, Zheng H W, Chen H, et al. Hepatitis B virus particles preferably induce Kupffer cells to produce TGF-β1 over pro-inflammatory cytokines[J]. Dig Liver Dis,2012,44(4):328-333. [3] Fan W, Liu T, Chen W, et al. ECM1 prevents activation of transforming growth factor β, hepatic stellate cells, and fibrogenesis in mice[J]. Gastroenterology,2019,157(5):1352-1367. [4] Sun Y, Zhou J, Wang L, et al. New classification of liver biopsy assessment for fibrosis in chronic hepatitis B patients before and after treatment[J]. Hepatology,2017,65(5):1438-1450. [5] Kleiner D E. On beyond staging and grading:Liver biopsy evaluation in a posttreatment world[J]. Hepatology, 2017,65(5):1432-1434. [6] Wang B, Sun Y, Zhou J, et al. Advanced septa size quantitation determines the evaluation of histological fibrosis outcome in chronic hepatitis B patients[J]. Mod Pathol, 2018,31(10):1567-1577. [7] Chen S, Duan W, Li M, et al. Prognosis of 732 ursodeoxycholic acid-treated patients with primary biliary cholangitis:A single center follow-up study from China[J]. J Gastroenterol Hepatol, 2019,34(7):1236-1241. [8] Li S X, Lv T T, Zhang C P, et al. Alteration of liver-infiltrated and peripheral blood double-negative T-cells in primary biliary cholangitis[J]. Liver Int,2019,39(9):1755-1767. [9] Lv T, Zhang W, Xu A, et al. Non-HFE mutations in haemochromatosis in China:combination of heterozygous mutations involving HJV signal peptide variants[J]. J Med Genet, 2018,55(10):650-660. [10] Zhang W, Xu A, Li Y, et al. A novel SLC40A1 p.Y333H mutation with gain of function of ferroportin:A recurrent cause of haemochromatosis in China[J]. Liver Int, 2019,39(6):1120-1127. [11] Li X, Zhang W, Zhou D, et al. Complex ATP7B mutation patterns in Wilson disease and evaluation of a yeast model for functional analysis of variants[J]. Hum Mutat,2019,40(5):552-565. |